Cornell has established the Department of Design Tech, a Radical Collaboration partnership between five colleges that seeks to enhance design and technology education and research across the university.
Endothelial cells – the cells that line blood vessels – grown alongside leukemia cells become corrupted and rescue the cancer cells from many chemotherapy drugs, a study by Weill Cornell Medicine investigators found.
Together, Matt Hall, Parfait Eloundou-Enyegue, and their faculty colleagues at the Cornell Population Center are pushing the traditional limits of their disciplines to find creative ways to meet a generation that could be defined by major population transformations. This includes leveraging demographic and big data tools to analyze how older populations navigate their communities, how racial diversity shapes patterns of marriage and childbearing, and how accelerating migration may undermine repressive political regimes.
Andrew Turner ’88, M.P.S. ’93, has been appointed director of Cornell Cooperative Extension (CCE) and associate dean for the College of Agriculture and Life Sciences (CALS) and the College of Human Ecology (CHE).
Disruption of the circadian clocks that keep the body and its cells entrained to the 24-hour day-night cycle plays a critical role in weight gain, according to a pair of studies by Weill Cornell Medicine investigators.
A study suggests boosting “naturally-produced” antibodies in mothers may enhance infants’ immunity against bacterial pathogens that cause infectious gastrointestinal diseases.
As journalists and professional fact-checkers struggle to keep up with the deluge of misinformation online, fact-checking sites that rely on loosely coordinated contributions from volunteers, such as Wikipedia, can help fill the gaps, Cornell research finds.
Collaboration was the theme of the evening at the second annual Community Engagement Awards, held April 16 and hosted by the Einhorn Center for Community Engagement to celebrate excellence in local and global university-community partnerships.
Genetically engineered immune cells successfully target the specific cancer cells that may be responsible for relapse of acute myeloid leukemia, according to a preclinical study by investigators at Weill Cornell Medicine.